Edward Nieuwenhuis, DPM
Foot & Ankle Surgery · Wyckoff, NJNPI 1477573541
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,500 of the $4,597 with a category attached, or 76.1%. Fusion Orthopedics USA, LLC accounts for 80.3% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $3,845 and has fallen 91.0% since, to $346 in 2025.
Across 30 payments — averaging $153.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fusion Orthopedics USA, LLC$4K
- Kerecis Limited$199
- Organogenesis Inc.$164
- Next Science LLC$129
- Stryker$128
- Treace Medical Concepts, Inc.$83
- plus $202 from 8 others
What the payments were for
- Consulting fees$3,50076%
- Food & beverage$1,09724%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fusion Orthopedics USA, LLC | 5 | $3,692 |
| Kerecis Limited | 2 | $199 |
| Organogenesis Inc. | 6 | $164 |
| Next Science LLC | 1 | $129 |
| Stryker | 3 | $128 |
| Treace Medical Concepts, Inc. | 3 | $83 |
| Integra Lifesciences Corporation | 2 | $56 |
| Orthofix Medical, Inc. | 1 | $30 |
| Merck | 2 | $26 |
| Zimmer Biomet | 1 | $22 |
| Paragon 28, Inc. | 1 | $21 |
| Smith+Nephew | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$551
- Kerecis GraftGuide$138
- Xperience$129
- BlastX$129
How this compares
$4,597 in reported general payments places this provider in the 70th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 41 | $923 |
| Colchicine | 11 | $580 |
| Ciclopirox | 14 | $572 |
| CiclopiroxCiclopirox Olamine | 29 | $548 |
| Doxycycline Hyclate | 38 | $501 |
| Cefadroxil | 51 | $423 |
| Allopurinol | 25 | $376 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 55 | $336 |
| Mupirocin | 24 | $178 |
| Clobetasol Propionate | 11 | $124 |
| Ibuprofen | 32 | $109 |
| Methylprednisolone | 15 | $88 |
| Meloxicam | 22 | $34 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Wyckoff
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$843K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Mark SolomonCedar Knolls$232K
- Evan AdlerOld Bridge$195K
- Shane HollawellManasquan$169K
- Jacob ReinkrautRidgewood$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.